Business Description
Bod Science Ltd
ISIN : AU0000181331
Description
Bod Science Ltd is a healthcare company combining the power of nature and science to deliver cannabis-derived health and skincare products, designed to improve lives and transform the medicinal cannabis, CBD, and hemp market. The firm is focused on cannabis drug development and products. The company is focused on progressing Research and Development and a defined clinical trial pathway to commercialize and deliver premium, scientifically trusted products for the consumer and medical markets. It earned it profits and sales revenue from Australia even though have segment in UK, Europe and USA.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.24 | |||||
| Equity-to-Asset | -2.31 | |||||
| Debt-to-Equity | -0.34 | |||||
| Debt-to-EBITDA | -0.3 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -35.97 | |||||
| Beneish M-Score | -9.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -57.5 | |||||
| 3-Year EBITDA Growth Rate | 3.5 | |||||
| 3-Year EPS without NRI Growth Rate | 26 | |||||
| 3-Year FCF Growth Rate | 34.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.3 | |||||
| Quick Ratio | 0.21 | |||||
| Cash Ratio | 0.06 | |||||
| Days Inventory | 257.49 | |||||
| Days Sales Outstanding | 61.47 | |||||
| Days Payable | 1964.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.2 | |||||
| Shareholder Yield % | -63.31 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.48 | |||||
| Operating Margin % | -429.13 | |||||
| Net Margin % | -741.39 | |||||
| FCF Margin % | -332.14 | |||||
| ROA % | -262.25 | |||||
| ROIC % | -195.13 | |||||
| ROC (Joel Greenblatt) % | -10347.54 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6 | |||||
| EV-to-EBIT | -0.51 | |||||
| EV-to-EBITDA | -0.52 | |||||
| EV-to-Revenue | 3.69 | |||||
| EV-to-FCF | -1.11 | |||||
| Earnings Yield (Greenblatt) % | -196.08 | |||||
| FCF Yield % | -67.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bod Science Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.865 | ||
| EPS (TTM) (A$) | -0.037 | ||
| Beta | 2.48 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (A$) | 0 | ||
| 20-Day SMA (A$) | 0.024 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (A$) | 0.024 - 0.024 | ||
| Shares Outstanding (Mil) | 177.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bod Science Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bod Science Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bod Science Ltd Frequently Asked Questions
What is Bod Science Ltd(ASX:BOD)'s stock price today?
The current price of ASX:BOD is A$0.02. The 52 week high of ASX:BOD is A$0.02 and 52 week low is A$0.02.
When is next earnings date of Bod Science Ltd(ASX:BOD)?
The next earnings date of Bod Science Ltd(ASX:BOD) is .
Does Bod Science Ltd(ASX:BOD) pay dividends? If so, how much?
Bod Science Ltd(ASX:BOD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers